Arkolith/Insider Trading/BMEA/Form 4

A2A Pharmaceuticals, Inc.

10% OwnerBiomea Fusion, Inc. (BMEA) · full profile →Form 4 · filed Aug 19, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$426K
Net Open-Market Flow
-$426K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2022Sell(P)31K$13.87$426K4.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859061-22-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML